MORI-MEMORIAL-FOUNDATION
8.12.2020 07:02:13 CET | Business Wire | Press release
London, New York, Tokyo, Paris and Singapore once again emerged as the world’s most comprehensively attractive cities, in that order, in the Global Power City Index (GPCI) 2020 report. This report is published by The Mori Memorial Foundation’s Institute for Urban Strategies , a research body established by Mori Building , a leading urban developer in Tokyo. Although the composition of the top five cities has remained unchanged since 2016, London and New York have shown a marked uptrend over that time while the scores of Tokyo and Paris have slipped, and Singapore has closed in on Paris. Among the other cities in the top 10, Berlin extended its scores in the area of Livability, leapfrogging Seoul into seventh place overall. Shanghai improved its ratings in all areas aside from Research and Development, greatly improving its overall position from #30 to #10 and overtaking Sydney to enter the top 10 for the first time.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201207005386/en/
Since 2008, the annual GPCI report has ranked 40 or more major cities in terms of their “magnetism,” or their overall power to attract creative individuals and enterprises from around the world. Cities are rated on the basis of 70 indicators in six functions: Economy, R&D, Cultural Interaction, Livability, Environment, and Accessibility. In an effort to reflect changes in the conditions affecting global cities, the GPCI continuously fine-tunes its indicators and data-collection methods.
In 2020, the most serious event was the spread of the novel coronavirus (COVID-19), labeled by the WHO in March as a global pandemic. COVID-19 subsequently had a wide-ranging impact on cities' economic networks and lifestyles as a result of the accompanying lockdowns, travel prohibitions and other restrictions on people’s movements. In the GPCI 2020 survey, conducted in August this year, the influence of the COVID-19 pandemic was reflected in a number of indicators, including “Workstyle Flexibility” and “Satisfaction with Urban Cleanliness”. With the accompanying transition to online working, internet speed was added as a factor to “Variety of Workplace Options”. On top of these changes, new indicators such as “Air Quality”, “Number of Flight Arrivals and Departures” and “Ease of Mobility by Taxi or Bicycle” were added. Moreover, based on a separate survey of urban lifestyle changes, some factors emerged which might be added as new criteria in the GPCI evaluation process.
Highlights (Cities from #1-10)
- London (#1), maintaining its #1 position for the ninth consecutive year, was placed in the top 10 of all categories aside from Environment. It achieved a remarkable improvement in Accessibility where it took first place, replacing Paris, while maintaining its comprehensive lead in the area of Cultural Interaction. On the other hand, its score in the Economy field fell for the second year running following a drop in its “GDP Growth Rate”. It will become even more important for London to maintain its overwhelming strength in Cultural Interaction if there is economic fallout as a result of COVID-19, which continues to affect people’s movements and interaction.
- New York (#2) was once again dominant in the Economy category this year, with improved scores in “Total Employment” and “Employees in Business Support Services”; it also secured the highest ratings in “Variety of Workplace Options”. Though the city maintained its top ranking in Research & Development and Cultural Interaction, its scores in “Workstyle Flexibility” fell, causing it to drop in the Livability rankings, the city’s weakest area. Given the impact of COVID-19 and the political divisions in the United States, Livability is a key area where the city should seek improvements.
- Tokyo (#3) continued to display consistent strengths in all areas while also raising its score in the area of Environment and Accessibility. Despite Japan’s capital retaining third place in the Economy field, the gap between it and next-placed Singapore narrowed. Livability was the only area where the city's rankings fell, due to a drop in scores for “Workstyle Flexibility”. The city has improved its position in Cultural Interaction since it was selected as an Olympic host city in 2013, yet it still has a potential for improvement in “Nightlife Options” and “Number of Luxury Hotel Rooms.”
- Paris (#4) fell back somewhat, in a reversal of its improved ratings last year. Although the city boosted its score in the Economy category as a result of improved scores in “Corporate Tax Rates”, it fell from first place in the areas of Livability and Accessibility. Its ranking in the area of Environment also fell due to low scores in “Satisfaction with Urban Cleanliness”, possibly as a result of the strike action by city sanitation workers in February 2020.
- Singapore (#5) reaffirmed its credentials as a stable city, achieving improved rankings in all areas except Cultural Interaction. The city state, a global business hub, raised its scores in the Economy field and closed the gap in this area on third-placed Tokyo. It overtook Hong Kong to claim first position in “Economic Freedom” and also improved its score in “Variety of Workplace Options” (#3). Competition with other Asian financial centers such as Tokyo and Hong Kong is expected to intensify.
- Amsterdam (#6) achieved first place in the area of Livability, replacing Paris, due largely to an improvement in its “Total Unemployment Rate” scores. The city was also rated highest overall in terms of “Ease of Mobility by Taxi or Bicycle” and took second place overall in Accessibility. However, its score in the Environment category dropped sharply due to low ratings in “Satisfaction with Urban Cleanliness”.
- Berlin (#7) overtook Seoul in the overall rankings, achieving significantly improved Livability scores, particularly in “Workstyle Flexibility” and with improved “Commitment to Climate Action” ratings helping to boost its performance in the Environment field. However, its rankings in “Variety of Workplace Options” fell and its weak position in Economy (#29) was unchanged from last year.
- Seoul (#8) greatly improved its ranking in Environment with strong ratings in “Waste Recycle Rate” (#2) and significant improvement in “Comfortable Temperature Levels”. In the Livability category, the city scored worst in “Workstyle Flexibility”, dropping from #34 to #39 position. It maintained its strong position in Research & Development, scoring in the top 10 in five out of eight indicators.
- Hong Kong (#9) saw improved ratings in the Economy area with very high scores in “Variety of Workplace Options” (#2) and “Economic Freedom”. It also raised its score in Research & Development due to improvements in “Number of Researchers” and “Number of Patents”. On the other hand, its ranking in the Cultural Interaction field fell from #13 to #20 due to a drop in scores for “Tourist Attractions” and “Attractiveness of Shopping Options”.
- Shanghai (#10) made the biggest jump in overall ratings in 2020, from #30 to #10. The main reason for this was its dramatic improvement in “Variety of Workplace Options”(#16) in the Economy area, as well as “Workstyle Flexibility” in Livability, where the city scored the highest in the wake of the COVID-19 pandemic. Experiencing the impact of COVID-19 earlier than many other cities, Shanghai took the opportunity to accelerate the development new ways of working.
The full press release of Mori Memorial Foundation’s GPCI 2020 Report can be viewed at the following link:
http://www.mori-m-foundation.or.jp/pdf/GPCI2020_release_en.pdf
(in English)
View source version on businesswire.com: https://www.businesswire.com/news/home/20201207005386/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma4.11.2026 15:13:00 CET | Press release
If approved, BRUKINSA plus rituximab would be the first and only chemotherapy-free, BTK inhibitor-based regimen for adult patients with previously untreated mantle cell lymphomaApplication supported by Phase 3 MANGROVE data, showing a 43% reduction in the risk of progression or death versus bendamustine plus rituximabFull MANGROVE results to be presented during the Plenary Scientific Session at the 68th American Society of Hematology Annual Meeting BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental New Drug Application (sNDA) for BRUKINSA® (zanubrutinib) in combination with rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The application is supported by data from the pivotal Phase 3 MANGROVE study, in which this chemotherapy-free regimen significantly reduced the risk of dis
Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement4.11.2026 15:00:00 CET | Press release
This framework agreement provides all entities subject to the French Public Procurement Code with simplified access to a support alternative enabling them to control their costs, preserve their freedom of technological choice and free themselves from vendor-imposed upgrade cycles Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced that it had been selected as the awardee of the third-party support service lots (TMA) by CANUT, the French public purchasing center specializing in digital technology and telecommunications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104431817/en/ Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement Eligible public organizations subject to the French Public Procurement Code can now benefit from Rimini Street services for their Oracle, SAP, VMw
Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 20264.11.2026 15:00:00 CET | Press release
New data in myeloproliferative neoplasms (MPNs) will include INCA033989, Incyte’s first-in-class, mutant calreticulin (mutCALR)-targeted monoclonal antibody, in first-line myelofibrosis (MF); and preclinical findings for Incyte’s next-generation mutCALR- and JAK2V617F-targeted compoundsUpdated results for INCA033989 in second-line MF and second-line essential thrombocythemia (ET) will build on previously presented datasetsLong-term Phase 1/2 data further characterize the potential of latarcibart (VGA039), an investigational Protein S-targeting antibody, as prophylaxis in adolescents and adults with von Willebrand disease (VWD)More than 30 abstracts will highlight progress across Incyte’s broader hematology portfolioIncyte will host an investor event and webcast on Saturday, December 12, 2026 from 7:30 – 9:00 p.m. CT (8:30 – 10:00 p.m. ET) Incyte (Nasdaq:INCY) today announced that new data highlighting progress across its hematology portfolio will be presented across more than 30 abstra
Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations4.11.2026 15:00:00 CET | Press release
Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibrosis (MF) and polycythemia vera (PV). Zenitar launched randomized Phase 2 FM-MF-02 (NCT07750574) in the US, Canada and Brazil to select Phase 3 dose for JAKi-naïve and refractory MF. Randomized FMF-02 (NCT06457425) met its week-24 endpoints: superior SVR35 and TSS50 with FM 50/100mg versus ruxolitinib; previous data presented orally at ASH24 (#486) and ASH25 (#908). ASH 2026 presence covers FMF-02 long-term follow-up (oral presentation, #411, December 12, 4:30pm) and refractory PV Phase 2 data (poster, #3765, December 13, 6pm), both in Session 634. “Over the 15 years since the initial FDA approval of Ruxolitinib, JAKi have markedly improved the prognosis of many patients with MF. The long-term data show significant room for improvement for this key therapeutic class in terms of both e
Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer4.11.2026 14:41:00 CET | Press release
Trained Therapeutix Discovery ("TTxD"), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulate innate immunity, announces the appointment of Andrew Glass as Chief Executive Officer with immediate effect. Mr. Glass has more than 20 years of leadership experience in the life sciences industry as Chief Executive Officer of Vivasure Medical and previously from over 15 years in senior leadership roles at Abbott. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104178009/en/ Andrew Glass, CEO, TTxD Following the previously announced changes to the Company’s Board earlier this year, Mr. Glass joins the Company as it transitions from preclinical stage to being a clinical-stage organisation. His expertise in developmental strategy, financing and organisational growth is focussed on expediting the delivery of the aims associated with TTxD’s proprietary
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
